Smith & Nephew SNATS’s (SNN) Neutral Rating Reiterated at JPMorgan Chase & Co.

JPMorgan Chase & Co. reissued their neutral rating on shares of Smith & Nephew SNATS (NYSE:SNN) in a report published on Thursday, Marketbeat.com reports.

A number of other equities analysts also recently commented on SNN. The Goldman Sachs Group restated a “buy” rating on shares of Smith & Nephew SNATS in a report on Monday, May 25th. Weiss Ratings cut shares of Smith & Nephew SNATS from a “hold (c+)” rating to a “hold (c)” rating in a report on Thursday, June 11th. Sanford C. Bernstein set a $31.85 price objective on shares of Smith & Nephew SNATS in a research report on Monday, May 11th. Morgan Stanley restated an “overweight” rating on shares of Smith & Nephew SNATS in a report on Wednesday. Finally, Barclays cut shares of Smith & Nephew SNATS from an “equal weight” rating to an “underweight” rating in a research report on Wednesday. Two analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $30.93.

Smith & Nephew SNATS Stock Performance

NYSE SNN opened at $30.10 on Thursday. Smith & Nephew SNATS has a fifty-two week low of $28.56 and a fifty-two week high of $38.79. The stock has a 50 day simple moving average of $30.46 and a two-hundred day simple moving average of $32.12. The company has a current ratio of 2.14, a quick ratio of 1.25 and a debt-to-equity ratio of 0.62.

Smith & Nephew SNATS Announces Dividend

The company also recently declared a dividend, which will be paid on Friday, November 6th. Investors of record on Friday, October 2nd will be given a dividend of $0.312 per share. The ex-dividend date is Friday, October 2nd. This represents a dividend yield of 205.0%.

Hedge Funds Weigh In On Smith & Nephew SNATS

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new stake in Smith & Nephew SNATS in the second quarter worth about $505,323,000. Bank of New York Mellon Corp purchased a new position in shares of Smith & Nephew SNATS during the second quarter valued at approximately $89,325,000. Goldman Sachs Group Inc. lifted its holdings in shares of Smith & Nephew SNATS by 49.2% during the first quarter. Goldman Sachs Group Inc. now owns 1,771,401 shares of the medical equipment provider’s stock valued at $50,255,000 after purchasing an additional 583,809 shares during the last quarter. Bank of America Corp DE boosted its position in shares of Smith & Nephew SNATS by 139.9% in the 3rd quarter. Bank of America Corp DE now owns 987,274 shares of the medical equipment provider’s stock worth $35,828,000 after purchasing an additional 575,666 shares in the last quarter. Finally, Deutsche Bank AG bought a new stake in shares of Smith & Nephew SNATS in the 2nd quarter worth approximately $33,563,000. Hedge funds and other institutional investors own 25.64% of the company’s stock.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.